Private Equity

• Represented Cerberus in connection with its $1.5B leveraged acquisition of a major government defense contractor whose shares were publicly traded on the New York Stock Exchange.
• Represented Francisco Partners in connection with four concurrent acquisitions of technology companies based in the U.S., the United Kingdom, France, and the Netherlands  
• Represented Francisco Partners in connection as lead investor in the Series D and Series E preferred equity financings rounds of Kyruus, Inc.
• Represented an Australia-based health care technology company in its acquisition by a major US-based private equity firm.
• Represented Three Hills Capital Partners, a private equity sponsor based in the United Kingdom and Italy, in connection with its acquisition of a premier U.S.-based restaurant group.
• Advised several private equity firms focused on the renewable energy space in investment transactions and acquisitions.
• Represented HPH Specialized Fund I in connection with its leveraged acquisition of a leading nutraceutical company.
• Represented Signet Healthcare Partners in connection with a substantial growth equity financing of a fully vertically integrated generic pharmaceutical company, with participation across the value chain from intermediates, active pharmaceutical ingredients, and drug product manufacturing. 
• Represented General Atlantic in connection with growth equity investment in a financial advisory firm.
• Represented a private equity firm in a significant growth equity investment in a US-based company that concentrates on the development, manufacturing, and commercialization of generic pharmaceutical products.
• Advised a private equity firm consortium in the hostile takeover of a national security services company.
• Advised a clinical education technology company offering medical simulation solutions in the sale of the company to a private equity portfolio company that is the world’s leading manufacturer and marketer of anatomical models and medical simulation products used for health care and patient education.
• Represented a financial sponsor in the standby purchase of common stock issued by a publicly held advertising agency in connection with that company’s emergence from Chapter 11 bankruptcy proceedings.

Strategic Mergers and Acquisitions

• Advised one of the largest independent hotel, resort, and casino management and development firms in the United States in a joint venture with another leading independent developer, which involved a publicly registered dividend distribution, term loan, and private equity financing.
• Represented a publicly held international telecommunications company in multiple mergers and acquisitions throughout Latin America.
• Represented a major publicly held global staffing company in connection with a “merger of equals” with another publicly held global staffing and outsourcing company.
• Represented a major consumer products company in its acquisition — through a tender offer — of a large medical device company.
• Advised a global provider of overhaul and maintenance services for gas turbine engines in its acquisition of a UK-based company that provides aftermarket supply-chain management services for the aerospace, defense, and marine industries.
• Represented a manufacturer of industrial and transportation products in the sale of a Czech Republic–based heavy-duty truck manufacturer to a NYSE-listed multinational conglomerate.
• Represented a French investment banking firm in connection with the restructuring and sale of a specialty telecommunications company.
• Represented a publicly held telecommunications company in its acquisition by, and merger with, a major global telecommunications services company.
• Represented a Russian holding company in multiple mergers and acquisitions throughout Russia, the CIS, Europe, and the United States.
• Represented a publicly held company in numerous mergers and acquisitions in the renewable energy sector.
• Advised a publicly held subsidiary of an alternative energy company in connection with a $2.1 billion merger with another public company.

Capital Markets Transactions

• Represented a global investment bank in a $2 billion sovereign debt offering.
• Represented a global provider of overhaul and maintenance services for gas turbine engines in the financing of its acquisition of a UK-based provider of aftermarket supply chain management services for the aerospace, defense, and marine industries through a contemporaneous public offering of common stock and senior notes.
• Represented a global human capital management company in its concurrent public offering of common stock and convertible subordinated notes.
• Advised a major UK recruitment agency in connection with its spin-off from a NYSE-listed company as well as a public offering and listing of what was, at the time, the largest-ever listing on the London Stock Exchange.
• Represented a telecommunications company based in Latin America in its issuance and sale of senior subordinated notes in a 144A offering.
• Represented a “bulge bracket” investment banking firm in the initial public offering of the common shares of a global supplier of aftermarket aircraft engines, engine parts, and airframe components.
• Advised a “bulge bracket” investment banking firm in its transition from a private partnership to a leading publicly held company, which included the initial and secondary public offerings of its common shares and listing on the NYSE.
• Advised a real estate development company based in China in its initial public offering and Nasdaq listing.
• Represented several Special Purpose Acquisition Corporations (SPACs) in their initial public offerings and subsequent M&A transactions.

Venture Capital Transactions

• Represented a leading private equity and venture capital sponsor in a $30 million investment in Series D Preferred Shares of a Boston-based technology company.
• Represented a major venture capital fund in more than 40 preferred equity and convertible note investments in technology and life sciences companies based in the United States and throughout Europe.
• Represented a leading genetics testing company in connection with multiple Series Seed, Series A, and convertible debt financings.
• Represented a provider of predictive disease models and tissue-specific extracellular matrix (ECM) products in Series Seed and Series A investments.
• Represented several venture capital funds in early-stage investments in a major regional airline.

Fund Formation and Related Transactions

• Advising an investment manager focused on the nutraceutical sector in the formation of its second private equity fund following representation of the company in connection with its inaugural fund.
• Advising a $100 million venture debt fund investing in start-up and early stage companies operating in the “urbantech” sector, which includes, but is not limited to, infrastructure, local services, built environment, real estate, transportation, logistics, food, water, waste, energy and public health, safety, and administration.
• Represented a financial institution, including two leading Chinese companies and a US-based entity, in connection with the formation of a $2.5 billion private equity fund.
• Represented an investment manager in the formation of three venture capital funds focused on investments in oncology and cancer research companies.
• Represented a global private equity sponsor in a $450 million equity investment in a multinational asset manager with operations in Hong Kong, Singapore, German, France, and the United States.
• Represented a major global insurance company in the acquisition of a hedge fund complex with $22 billion of combined assets under management.